CEO says US biotech firm intends to submit new vaccine to regulators, will gear up to start supplying shots by August in anticipation of infection spike in the fall
Pfizer announced Saturday that tweaking its covid-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.
Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer people updated booster shots this fall.
By Carolyn Sung, CNN Two Pfizer and BioNTech Covid-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current Covid-19 vaccine, the companies said Saturday. The companies tested a vaccine that targets Omicron BA.
Pfizer said that tweaking its vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.
Pharma firm announces it has 'two very strong' candidates against the coronavirus variant, as US regulators set to weigh whether to offer updated boosters